Table 1.
Associations (χ2-tests) between the protein expression GOLPH2 in renal cell cancer and clinico-pathological parameters (percentages in brackets)
| Total | GOLPH2 low* | GOLPH2 high* | p-value | |
| All cases | 104 (100) | 59 (56.7)* | 45 (43.3)* | |
| Gender | 0.475 | |||
| men | 81 (77.9) | 44 (54.3) | 37 (45.7) | |
| women | 23 (22.1) | 15 (65.2) | 8 (34.8) | |
| Age | 0.236 | |||
| ≤ 62 | 56 (53.8) | 35 (62.5) | 21 (37.5) | |
| >62 | 48 (46.2) | 24 (50.0) | 24 (50.0) | |
| Histology | <0.001 | |||
| clear cell | 83 (79.8) | 58 (69.9) | 25 (29.1) | |
| chromophobe | 5 (4.8) | 0 (0.0) | 5 (100.0) | |
| papillary | 16 (15.4) | 1 (6.3) | 15 (93.7) | |
| pT-status | 1.000 | |||
| pT1 | 53 (51.0) | 30 (56.6) | 23 (43.4) | |
| pT2/3/4 | 51 (49.0) | 29 (56.9) | 22 (43.1) | |
| pN-status | 0.455 | |||
| pN0 | 50 (48.1) | 30 (60.0) | 20 (40.0) | |
| pN1 | 10 (9.6) | 6 (60.0) | 4 (40.0) | |
| pNx | 44 (42.3) | 23 (52.3) | 21 (47.7) | |
| Fuhrman grade | 0.347 | |||
| G 1 | 11 (10.6) | 8 (72.7) | 3 (27.3) | |
| G 2 | 74 (71.2) | 41 (55.4) | 33 (44.6) | |
| G 3/4 | 19 (18.2) | 10 (52.6) | 9 (47.4) | |
| Metastasis | 0.389 | |||
| M0/x | 83 (79.8) | 46 (55.4) | 37 (44.6) | |
| M1 | 21 (20.2) | 13 (61.9) | 8 (38.1) | |